The Global Neurovascular Guidewires Industry is poised for remarkable growth during the forecast period from 2022 to 2028, with a projected Compound Annual Growth Rate (CAGR) of 4.0%. This expansion is being driven by an increasing demand for straight-tip guidewires, particularly in the context of minimally invasive spine and cervical surgeries.

The latest research study by Future Market Insights highlights the following key findings:

  1. Straight Tip Guidewires Dominate: Straight-tip guidewires, currently constituting more than a third of the total market value, are set to maintain their dominant position in the neurovascular guidewires market through 2028. These guidewires are at the forefront of technological innovation and are instrumental in facilitating neurovascular procedures.
  2. Applications in Aneurysms and Angioplasty: Neurovascular guidewires find their highest applicability in aneurysms and intra- and extra-cranial angioplasty. This underscores the vital role they play in treating complex neurovascular conditions, offering improved patient outcomes.
  3. Hospitals Lead Revenue Generation: While hospitals may represent limited investment opportunities in the neurovascular guidewire market, they are expected to remain the leading end-use segment in terms of revenue generation. The stability and consistent demand from hospitals reflect their essential role in providing quality healthcare services.

This robust growth in the neurovascular guidewires industry signifies the industry’s commitment to innovation, patient well-being, and the pursuit of advanced healthcare solutions.

Request a Sample Report Now to get Premium Insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3121

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since their introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires industry. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue. Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped        and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

Revealing the key assumptions of the study. Ask the Expert for Insider Insights!
https://www.futuremarketinsights.com/ask-question/rep-gb-3121

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies pertaining to the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires industry as the patients are not required to pay from their own pocket.

FMI’s report tracks some of the key companies operating in the neurovascular guidewire market, which include Boston Scientific Corporation, Medtronic, Penumbra Inc., Stryker, Asahi Intecc Co. Ltd, Integer Holding Corporation, Cordis Corporation, CONMED Corporation, phenox GmbH, and Integer Holding Corporation, among others.

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-3121

Global Neurovascular Guidewires Industry by CategoryProduct:

  • Shapeable Tip Guidewires
  • Straight Tip Guidewires
  • Angled Tip Guidewires
  • Round curve Tip Guidewires

Application:

  • Arteriovenous Malformations
  • Intracranial and Extra-Cranial Angioplasty
  • Aneurysms
  • Minimally Invasive Spine surgery
  • Cerebral Angiography

Coating Type:

  • Hydrophilic Guidewires
  • Hydrophobic Guidewires

End User:

  • Hospitals
  • Laboratories
  • Research Institutes
  • Biopharmaceutical Companies
  • Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

 

Leave a comment

Your email address will not be published. Required fields are marked *